Open access
Sep 2026
Targeted Therapy, Immunotherapy, and Molecular Testing in Advanced Solid Tumors: A Medicare Analysis
This retrospective observational cohort study assessed biomarker testing and guideline‐concordant matched first‐line therapy use and evaluated their associations with overall survival, diagnosis‐to‐treatment intervals, and 6‐month physical functioning in patients with advanced solid tumors.
Onur Baser, Yi-Jia Sun
· Cancer Medicine · 0 citations